Can a with­drawn Eli Lil­ly drug find sec­ond life in ra­dio­phar­ma? Lit­tle biotech hands over $5M cash to find out

Three years af­ter Eli Lil­ly pulled Lartru­vo from the mar­ket, the soft tis­sue sar­co­ma drug is get­ting a sec­ond life.

Lit­tle Aus­tralia-list­ed biotech Telix Phar­ma­ceu­ti­cals …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER